10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001213900-22-015575 |
| Period End Date | 20211231 |
| Filing Date | 20220328 |
| Fiscal Year | 2021 |
| Fiscal Period | FY |
| XBRL Instance | f10k2021_aikidopharma_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
59 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred stock, par value (in Dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par value (in Dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, authorized |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Preferred stock, authorized |
PreferredStockSharesAuthorized
|
50.00M | shares | Point-in-time |
| Cash |
CashAndCashEquivalentsAtCarryingValue
|
$65.56M | USD | Point-in-time |
| Cash |
CashAndCashEquivalentsAtCarryingValue
|
$2.71M | USD | Point-in-time |
| Marketable securities |
MarketableSecurityCurrent
|
$24.80M | USD | Point-in-time |
| Marketable securities |
MarketableSecurityCurrent
|
$11.43M | USD | Point-in-time |
| Prepaid expenses and other assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$215.00K | USD | Point-in-time |
| Prepaid expenses and other assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$442.00K | USD | Point-in-time |
| Short-term investments at fair value |
ShortTermInvestments
|
$2.27M | USD | Point-in-time |
| Short-term investments at fair value |
ShortTermInvestments
|
- | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in Dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Notes receivable at fair value |
NotesReceivableRelatedPartiesCurrent
|
- | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Notes receivable at fair value |
NotesReceivableRelatedPartiesCurrent
|
$6.98M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Deposits |
DepositsAssetsCurrent
|
$4.20M | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
89.68M | shares | Point-in-time |
| Deposits |
DepositsAssetsCurrent
|
- | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
34.92M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
89.68M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$90.89M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$27.73M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
34.92M | shares | Point-in-time |
| Convertible note receivable at fair value |
NotesReceivableRelatedPartiesNoncurrent
|
- | USD | Point-in-time |
| Convertible note receivable at fair value |
NotesReceivableRelatedPartiesNoncurrent
|
$2.15M | USD | Point-in-time |
| Investments |
Investments
|
$9.46M | USD | Point-in-time |
| Investments |
Investments
|
$2.76M | USD | Point-in-time |
| Security deposit |
SecurityDeposit
|
- | USD | Point-in-time |
| Security deposit |
SecurityDeposit
|
$155.00K | USD | Point-in-time |
| Total assets |
Assets
|
$30.50M | USD | Point-in-time |
| Total assets |
Assets
|
$102.66M | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$381.00K | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$567.00K | USD | Point-in-time |
| Accrued salaries and benefits |
EmployeeRelatedLiabilitiesCurrent
|
$680.00K | USD | Point-in-time |
| Accrued salaries and benefits |
EmployeeRelatedLiabilitiesCurrent
|
$310.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.06M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$877.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$1.06M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$877.00K | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock value |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock value |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,681,258 and 34,920,222 shares issued at December 31, 2021 and 2020, respectively; 89,681,255 and 34,920,219 shares outstanding at December 31, 2021 and 2020, respectively |
CommonStockValue
|
$3.00K | USD | Point-in-time |
| Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,681,258 and 34,920,222 shares issued at December 31, 2021 and 2020, respectively; 89,681,255 and 34,920,219 shares outstanding at December 31, 2021 and 2020, respectively |
CommonStockValue
|
$9.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$186.48M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$265.62M | USD | Point-in-time |
| Treasury stock, at cost, 3 shares at December 31, 2021 and 2020 |
TreasuryStockValue
|
$264.00K | USD | Point-in-time |
| Treasury stock, at cost, 3 shares at December 31, 2021 and 2020 |
TreasuryStockValue
|
$264.00K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-156.60M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-163.77M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$29.62M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$101.59M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$10.53M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$30.50M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$102.66M | USD | Point-in-time |
Income Statement
26 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| General and administrative |
SellingGeneralAndAdministrativeExpense
|
$4.06M | USD | Annual |
| General and administrative |
SellingGeneralAndAdministrativeExpense
|
$7.73M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$1.02M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$559.00K | USD | Annual |
| Research and development - license acquired |
ResearchAndDevelopmentLicenseAcquired
|
$1.15M | USD | Annual |
| Research and development - license acquired |
ResearchAndDevelopmentLicenseAcquired
|
$1.47M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$6.55M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$9.44M | USD | Annual |
| Loss from operations |
OperatingIncomeLoss
|
$-6.55M | USD | Annual |
| Loss from operations |
OperatingIncomeLoss
|
$-9.44M | USD | Annual |
| Other income |
OtherIncome
|
$135.00K | USD | Annual |
| Other income |
OtherIncome
|
$19.00K | USD | Annual |
| Interest income |
InterestIncomeExpenseNet
|
- | USD | Annual |
| Interest income |
InterestIncomeExpenseNet
|
$252.00K | USD | Annual |
| (Loss) gains on marketable securities |
MarketableSecuritiesGainLoss
|
$1.00M | USD | Annual |
| (Loss) gains on marketable securities |
MarketableSecuritiesGainLoss
|
$-1.74M | USD | Annual |
| Change in fair value of investment |
GainLossOnInvestments
|
$-6.81M | USD | Annual |
| Change in fair value of investment |
GainLossOnInvestments
|
$3.63M | USD | Annual |
| Total other income (expenses) |
OtherNonoperatingIncomeExpense
|
$-5.79M | USD | Annual |
| Total other income (expenses) |
OtherNonoperatingIncomeExpense
|
$2.27M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-7.17M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-12.34M | USD | Annual |
| Basic and Diluted (in Dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.44 | USD | Annual |
| Basic and Diluted (in Dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.09 | USD | Annual |
| Basic and Diluted (in Shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
28.07M | shares | Annual |
| Basic and Diluted (in Shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
82.40M | shares | Annual |
Cash Flow Statement
64 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-7.17M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-12.34M | USD | Annual |
| Change in fair value of investment |
ChangeInFairValueOfInvestments
|
$-3.63M | USD | Annual |
| Change in fair value of investment |
ChangeInFairValueOfInvestments
|
$6.81M | USD | Annual |
| Research and development-acquired license, expensed |
ResearchAndDevelopmentacquiredLicenseExpensed
|
$1.47M | USD | Annual |
| Research and development-acquired license, expensed |
ResearchAndDevelopmentacquiredLicenseExpensed
|
$1.15M | USD | Annual |
| Stock-based compensation |
ShareBasedCompensation
|
$84.00K | USD | Annual |
| Stock-based compensation |
ShareBasedCompensation
|
$314.00K | USD | Annual |
| Realized loss (gain) on marketable securities |
MarketableSecuritiesRealizedGainLoss
|
$-67.00K | USD | Annual |
| Realized loss (gain) on marketable securities |
MarketableSecuritiesRealizedGainLoss
|
$509.00K | USD | Annual |
| Unrealized loss on marketable securities |
MarketableSecuritiesUnrealizedGainLoss
|
$-218.00K | USD | Annual |
| Unrealized loss on marketable securities |
MarketableSecuritiesUnrealizedGainLoss
|
$-3.12M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$227.00K | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$34.00K | USD | Annual |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-186.00K | USD | Annual |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$499.00K | USD | Annual |
| Accrued salaries and benefits |
IncreaseDecreaseInAccruedSalaries
|
$370.00K | USD | Annual |
| Accrued salaries and benefits |
IncreaseDecreaseInAccruedSalaries
|
$-372.00K | USD | Annual |
| Interest receivable on convertible note |
IncreaseDecreaseInNotesReceivables
|
$252.00K | USD | Annual |
| Interest receivable on convertible note |
IncreaseDecreaseInNotesReceivables
|
- | USD | Annual |
| Security deposit |
IncreaseDecreaseInSecurityDeposits
|
$-155.00K | USD | Annual |
| Security deposit |
IncreaseDecreaseInSecurityDeposits
|
- | USD | Annual |
| Payable to DatChat |
IncreaseDecreaseInPayablesToDatchat
|
- | USD | Annual |
| Payable to DatChat |
IncreaseDecreaseInPayablesToDatchat
|
$150.00K | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.02M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-6.60M | USD | Annual |
| Purchase of marketable securities |
PurchaseOfMarketableSecurities
|
$98.83M | USD | Annual |
| Purchase of marketable securities |
PurchaseOfMarketableSecurities
|
$93.43M | USD | Annual |
| Sale of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$74.87M | USD | Annual |
| Sale of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$103.04M | USD | Annual |
| Proceeds from sale of Hoth common shares |
ProceedsFromSaleOfCommonStock
|
- | USD | Annual |
| Proceeds from sale of Hoth common shares |
ProceedsFromSaleOfCommonStock
|
$460.00K | USD | Annual |
| Proceeds from sale of DatChat common shares |
ProceedsFromSaleOfDatChatCommonShares
|
- | USD | Annual |
| Proceeds from sale of DatChat common shares |
ProceedsFromSaleOfDatChatCommonShares
|
$900.00K | USD | Annual |
| Funds to deposit accounts, net |
FundsToDepositAccounts
|
$4.20M | USD | Annual |
| Funds to deposit accounts, net |
FundsToDepositAccounts
|
- | USD | Annual |
| Purchase of short-term investments |
PaymentsToAcquireInvestments
|
- | USD | Annual |
| Purchase of short-term investments |
PaymentsToAcquireInvestments
|
$5.67M | USD | Annual |
| Purchase of research and development licenses |
UnpaidInvestment
|
$-617.00K | USD | Annual |
| Purchase of research and development licenses |
UnpaidInvestment
|
$-1.47M | USD | Annual |
| Purchase of convertible note |
RepaymentOfConvertibleDebt
|
- | USD | Annual |
| Purchase of convertible note |
RepaymentOfConvertibleDebt
|
$2.00M | USD | Annual |
| Purchase of short-term notes |
PaymentsToAcquireShortTermInvestments
|
$6.88M | USD | Annual |
| Purchase of short-term notes |
PaymentsToAcquireShortTermInvestments
|
- | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-8.85M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-24.96M | USD | Annual |
| Proceeds from issuance of common stock and warrants, net of offering cost |
ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost
|
$6.56M | USD | Annual |
| Proceeds from issuance of common stock and warrants, net of offering cost |
ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost
|
$78.22M | USD | Annual |
| Proceeds from issuance of common stock, net of offering cost |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Proceeds from issuance of common stock, net of offering cost |
ProceedsFromIssuanceOfCommonStock
|
$17.84M | USD | Annual |
| Proceeds from exercise of warrants |
ProceedsFromWarrantExercises
|
$7.20M | USD | Annual |
| Proceeds from exercise of warrants |
ProceedsFromWarrantExercises
|
$84.00K | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$31.61M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$78.30M | USD | Annual |
| Net increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$2.62M | USD | Annual |
| Net increase in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$62.85M | USD | Annual |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$91.00K | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.71M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$65.56M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$91.00K | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.71M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$65.56M | USD | Point-in-time |
| Distribution of Hoth common stock |
DistributionOfHothCommonStock
|
- | USD | Annual |
| Distribution of Hoth common stock |
DistributionOfHothCommonStock
|
$269.00K | USD | Annual |
Stockholders Equity
22 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net of offering costs |
WarrantNetOfferingCosts
|
$8.03M | USD | Annual |
| Net of offering costs |
WarrantNetOfferingCosts
|
$941.00K | USD | Annual |
| Net of offering costs |
NetOfOfferingCostsWarrants
|
$1.91M | USD | Annual |
| Balance |
StockholdersEquity
|
$29.62M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$101.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$10.53M | USD | Point-in-time |
| Issuance of common stock, common warrants and prefunded warrants, net of offering cost (net of offering costs of $941) |
StockIssuedDuringPeriodValueOther
|
$6.56M | USD | Annual |
| Issuance of common stock, net of offering cost (net of offering costs of $1,905) |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$17.84M | USD | Annual |
| Common warrant and prefunded warrant exercise |
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
|
$7.20M | USD | Annual |
| Distribution of Hoth common stock |
DistributionOfHothCommonStock
|
- | USD | Annual |
| Distribution of Hoth common stock |
DistributionOfHothCommonStock
|
$269.00K | USD | Annual |
| Issuance of common stock and warrants (net of offering costs of $8,031) |
StockIssuedDuringPeriodValueOfCommonStockAndWarrants
|
$78.22M | USD | Annual |
| Exercise of warrants |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$84.00K | USD | Annual |
| Issuance of common stock for research and development license acquired |
StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired
|
$531.00K | USD | Annual |
| Conversion of Series D Preferred stock |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
- | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
|
$84.00K | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
|
$314.00K | USD | Annual |
| Net loss |
ProfitLoss
|
$-12.34M | USD | Annual |
| Net loss |
ProfitLoss
|
$-7.17M | USD | Annual |
| Balance |
StockholdersEquity
|
$29.62M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$101.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$10.53M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.